01 May 2023

Neurosoft Bioelectronics Awarded CHF 2.5M Swiss Accelerator Grant!

Neurosoft Bioelectronics was selected by Innosuisse as one of 53 projects (out of 752 applicants) and will receive funding to continue development of innovative minimally-invasive Brain Computer Interfaces

We are proud to announce that we have been awarded a Swiss Accelerator grant of CHF 2.5M ($2.8M) to develop our minimally invasive Brain-Computer Interface. Along with 52 other outstanding projects (out of an initial 752 applicants), we will be supported by Innosuisse to achieve our mission and vision of helping millions of people worldwide suffering from severe neurological disorders.

Congratulations to all the other teams and thank you to Innosuisse for supporting startup companies during these times. We are excited to continue our journey and to share more details and updates in the following weeks.

Read more here.

Minimally Invasive Brain-Computer Interface published in Science Robotics

Neurosoft Bioelectronics adds experts in Neuromodulation & Tinnitus to its Advisory Board